Erleada 60 MG tablet UU 120S
Ended Awarded Last action
- Contract number
- SPE2DR26FQV0A
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,932
Award facts
- Contract value 100% obligated
- $15,931.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $15,931.60 to AmerisourceBergen Drug Corp on January 21, 2026, for the supply of Erleada 60 mg tablets (120 count). The contract utilizes a firm fixed-price structure with no set-aside designation, indicating competitive award through open competition. Performance will be fulfilled at the awardee's facility in Conshohocken, Pennsylvania, with an ultimate completion date of February 11, 2026. This delivery order is executed under AmerisourceBergen Drug Corp's parent company, Cencora, Inc., which holds a significant $999.99 million indefinite delivery contract with DLA Troop Support Medical through December 2031 that serves as the foundational vehicle for pharmaceutical and medical supply procurement across military healthcare systems globally.
Erleada (apalutamide) is a prescription medication used in the treatment of prostate cancer, reflecting the Defense Logistics Agency's ongoing procurement of specialized oncology medications to support military treatment facilities and veteran healthcare programs. AmerisourceBergen Drug Corp, operating as a subsidiary of Cencora, Inc., is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement needs. The delivery order represents a routine task order execution under the larger indefinite delivery contract framework that enables efficient, flexible sourcing of essential pharmaceutical commodities across multiple therapeutic domains to support Department of Defense healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FQV0A?
SPE2DR26FQV0A was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26FQV0A worth?
The government has obligated $15,932 on SPE2DR26FQV0A.
Is contract SPE2DR26FQV0A an order under another contract?
Yes. SPE2DR26FQV0A is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQV0A competed?
The extent of competition for SPE2DR26FQV0A was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award